H2AJ Human Pre-designed siRNA Set A contains three designed siRNAs for H2AJ gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H2AX Human Pre-designed siRNA Set A contains three designed siRNAs for H2AX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H2AZ1 Human Pre-designed siRNA Set A contains three designed siRNAs for H2AZ1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H2BC11 Human Pre-designed siRNA Set A contains three designed siRNAs for H2BC11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H2BC12 Human Pre-designed siRNA Set A contains three designed siRNAs for H2BC12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H3-3A Human Pre-designed siRNA Set A contains three designed siRNAs for H3-3A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H3-3B Human Pre-designed siRNA Set A contains three designed siRNAs for H3-3B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H3-4 Human Pre-designed siRNA Set A contains three designed siRNAs for H3-4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H3-5 Human Pre-designed siRNA Set A contains three designed siRNAs for H3-5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H3-7 Human Pre-designed siRNA Set A contains three designed siRNAs for H3-7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H3B-8800 is a potent and orally active SF3B splicing modulator. H3B-8800 direct interaction with the SF3b complex and shows anti-cancer activity. H3B-8800 has the potential for the research of acute myeloid leukemia (AML) with SF3B1 mutant[1].

H3B-8800 is a potent and orally active SF3B splicing modulator. H3B-8800 direct interaction with the SF3b complex and shows anti-cancer activity. H3B-8800 has the potential for the research of acute myeloid leukemia (AML) with SF3B1 mutant[1].

H3B-8800 is a potent and orally active SF3B splicing modulator. H3B-8800 direct interaction with the SF3b complex and shows anti-cancer activity. H3B-8800 has the potential for the research of acute myeloid leukemia (AML) with SF3B1 mutant[1].

H3C1 Human Pre-designed siRNA Set A contains three designed siRNAs for H3C1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H3C14 Human Pre-designed siRNA Set A contains three designed siRNAs for H3C14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H3C2 Human Pre-designed siRNA Set A contains three designed siRNAs for H3C2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H3C3 Human Pre-designed siRNA Set A contains three designed siRNAs for H3C3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H3C6 Human Pre-designed siRNA Set A contains three designed siRNAs for H3C6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H3C7 Human Pre-designed siRNA Set A contains three designed siRNAs for H3C7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H3C8 Human Pre-designed siRNA Set A contains three designed siRNAs for H3C8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H3Y2 Human Pre-designed siRNA Set A contains three designed siRNAs for H3Y2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H4C1 Human Pre-designed siRNA Set A contains three designed siRNAs for H4C1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H4C2 Human Pre-designed siRNA Set A contains three designed siRNAs for H4C2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H4C3 Human Pre-designed siRNA Set A contains three designed siRNAs for H4C3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H4C4 Human Pre-designed siRNA Set A contains three designed siRNAs for H4C4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H4C6 Human Pre-designed siRNA Set A contains three designed siRNAs for H4C6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H4C8 Human Pre-designed siRNA Set A contains three designed siRNAs for H4C8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

H6PD Human Pre-designed siRNA Set A contains three designed siRNAs for H6PD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Anti-HA tag Antibody is a non-conjugated and Rabbit origined monoclonal antibody. It can be used for WB, IF-Cell, IP assays in the background of .

HAAO Human Pre-designed siRNA Set A contains three designed siRNAs for HAAO gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HABP2 Human Pre-designed siRNA Set A contains three designed siRNAs for HABP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HABP4 Human Pre-designed siRNA Set A contains three designed siRNAs for HABP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HACD1 Human Pre-designed siRNA Set A contains three designed siRNAs for HACD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HACD2 Human Pre-designed siRNA Set A contains three designed siRNAs for HACD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HACD3 Human Pre-designed siRNA Set A contains three designed siRNAs for HACD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HACE1 Human Pre-designed siRNA Set A contains three designed siRNAs for HACE1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

hAChE/hBACE-1-IN-4 (compound AK-2) is a quinazoline derivative. hAChE/hBACE-1-IN-4 shows significant inhibitory activity against hAChE and hBACE-1 enzymes (hAChE, IC50=0.283 μM; hBACE-1, IC50=0.231 μM). hAChE/hBACE-1-IN-4 has the potential to inhibit Aβ aggregation. hAChE/hBACE-1-IN-4 has non-neurotoxicity , blood-brain barrier permeability and oral activity. hAChE/hBACE-1-IN-4 can be used in Alzheimer’s disease research[1].

HACL1 Human Pre-designed siRNA Set A contains three designed siRNAs for HACL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HADH Human Pre-designed siRNA Set A contains three designed siRNAs for HADH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HADHA Human Pre-designed siRNA Set A contains three designed siRNAs for HADHA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HADHB Human Pre-designed siRNA Set A contains three designed siRNAs for HADHB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HAGH Human Pre-designed siRNA Set A contains three designed siRNAs for HAGH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HAGHL Human Pre-designed siRNA Set A contains three designed siRNAs for HAGHL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HAL Human Pre-designed siRNA Set A contains three designed siRNAs for HAL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Halociline, a derivative of alkaloids, that can be isolated from the marine fungus Penicillium griseofulvum. Halociline targets MAPK1, MMP-9, and PIK3CA in gastric cancer cells, potentially mediated by diverse pathways including cancer, lipid metabolism, atherosclerosis, and EGFR tyrosine kinase inhibitor resistance. Halociline possesses antimicrobial, antioxidant and biofilm inhibitory activities[1][2].

HaloFlipper 30 is a fluorescent probe that covalently reacts with HaloTag fusion proteins to form an ester bond, which allows the probe to be stably attached to membrane structures. HaloFlipper 30 has high specificity, precision and good cell permeability[1].

Halofuginone (RU-19110) hydrobromid, a Febrifugine derivative, is a competitive prolyl-tRNA synthetase inhibitor with a Ki of 18.3 nM. Halofuginone hydrobromid is a specific inhibitor of type-I collagen synthesis and attenuates osteoarthritis (OA) by inhibition of TGF-β activity. Halofuginone hydrobromid is also a potent pulmonary vasodilator by activating Kv channels and blocking voltage-gated, receptor-operated and store-operated […]

Halofuginone (RU-19110) hydrobromid, a Febrifugine derivative, is a competitive prolyl-tRNA synthetase inhibitor with a Ki of 18.3 nM. Halofuginone hydrobromid is a specific inhibitor of type-I collagen synthesis and attenuates osteoarthritis (OA) by inhibition of TGF-β activity. Halofuginone hydrobromid is also a potent pulmonary vasodilator by activating Kv channels and blocking voltage-gated, receptor-operated and store-operated […]

HAMP Human Pre-designed siRNA Set A contains three designed siRNAs for HAMP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.